Xeris Biopharma Holdings, Inc. (XERS)
8.75
+0.01
(+0.11%)
USD |
NASDAQ |
Aug 25, 16:00
8.75
0.00 (0.00%)
After-Hours: 18:41
Xeris Biopharma Holdings Total Assets (Quarterly) : 411.90M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 411.90M |
| March 31, 2026 | 392.01M |
| December 31, 2025 | 392.94M |
| September 30, 2025 | 370.19M |
| June 30, 2025 | 334.69M |
| March 31, 2025 | 315.45M |
| December 31, 2024 | 329.15M |
| September 30, 2024 | 321.10M |
| June 30, 2024 | 331.73M |
| March 31, 2024 | 336.62M |
| December 31, 2023 | 340.80M |
| September 30, 2023 | 327.78M |
| June 30, 2023 | 328.78M |
| March 31, 2023 | 321.36M |
| December 31, 2022 | 344.64M |
| September 30, 2022 | 303.02M |
| June 30, 2022 | 318.62M |
| March 31, 2022 | 337.62M |
| Date | Value |
|---|---|
| December 31, 2021 | 304.72M |
| September 30, 2021 | 131.26M |
| June 30, 2021 | 151.50M |
| March 31, 2021 | 167.64M |
| December 31, 2020 | 159.15M |
| September 30, 2020 | 170.39M |
| June 30, 2020 | 165.81M |
| March 31, 2020 | 116.46M |
| December 31, 2019 | 108.99M |
| September 30, 2019 | 128.10M |
| June 30, 2019 | 133.89M |
| March 31, 2019 | 160.97M |
| December 31, 2018 | 120.03M |
| September 30, 2018 | 137.59M |
| June 30, 2018 | 138.26M |
| March 31, 2018 | 61.56M |
| December 31, 2017 | 45.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 302.71M |
| Aclaris Therapeutics, Inc. | 179.69M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 421.64M |
| Shareholders Equity (Quarterly) | -9.734M |
| Debt to Equity Ratio | -29.74 |
| Current Ratio | 1.449 |
| Net Debt Paydown Yield | -0.30% |